PEDMARK® REDUCED THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH HEPATOBLASTOMA, SEEN IN A TURKISH COMPASSIONATE USE TREATMENT PROTOCOL için istatistikler
Toplam ziyaret
| views | |
|---|---|
| PEDMARK® REDUCED THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH HEPATOBLASTOMA, SEEN IN A TURKISH COMPASSIONATE USE TREATMENT PROTOCOL | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Nisan 2024 | 0 |
| Mayıs 2024 | 0 |
| Haziran 2024 | 0 |
| Temmuz 2024 | 0 |
| Ağustos 2024 | 0 |
| Eylül 2024 | 0 |
| Ekim 2024 | 0 |
